《全日总结》恒指反覆升8点 京东快手弹 腾讯走弱
腾讯(00700.HK)宣布把部分新增盈利投资三大业务领域致股价受压,令港股今日反覆上落。恒指高开134点後掉头向下,曾跌163点一度低见28,286点,全日反覆升8点或0.03%,收28,458点;国指升59点或0.56%,收10,702点;恒生科技指数升109点或1.4%,收8,025点。大市全日成交总额1,519.02亿元,沪、深港通南下交易录得净流入金额分别为20.1亿及16.64亿元人民币。
腾讯股价跌3.4%报588.5元,为跌幅最大蓝筹。恒指服务公司收市後公布季检结果,多只染蓝热门股受捧。快手(01024.HK)升5.7%,平安好医生(01833.HK)及网易(09999.HK)各升5.4%及4.8%,京东(09618.HK)升2.8%报288.8元。农夫山泉(09633.HK)升6.4%。蓝月亮(06993.HK)亦炒上6.9%。李宁(02331.HK)升2.4%。
阿里巴巴(09988.HK)升1%报208元,小米(01810.HK)及美团(03690.HK)各升0.4%及0.7%,百度(09888.HK)升1.5%报188.7元,京东健康(06618.HK)升4.3%。金山软件(03888.HK)及恒腾(00136.HK)各跌2.4%及3.6%。手机部件股比亚迪电子(00285.HK)及信利(00732.HK)各升4.5%及4.2%,丘钛(01478.HK)、瑞声(02018.HK)、富智康(02038.HK)及舜宇(02382.HK)各升2.1%至2.7%。晶片股华虹半导体(01347.HK)升3%。
其余内需股方面,海底捞(06862.HK)升4.1%,颐海国际(01579.HK)跌3.6%。呷哺呷哺(00520.HK)撤换行政总裁,全日股价挫15%。医药股康哲药业(00867.HK)及绿叶制药(02186.HK)各升6.3%及5.5%,翰森制药(03692.HK)升4.2%,石药(01093.HK)、中生制药(01177.HK)、复星医药(02196.HK)及药明生物(02269.HK)各升逾2%。
澳门概念股造好,永利澳门(01128.HK)及澳博(00880.HK)各升2.5%及2.4%,信德(00242.HK)及美高梅中国(02282.HK)升3.8%及3.2%。
煤炭股兖煤(01171.HK)及中煤能源(01898.HK)各反弹3.7%及4.5%,钢铁股重庆钢铁(01053.HK)弹高10.8%。中铝(02600.HK)及宏桥(01378.HK)各升4.6%及3.2%。航运股中远海控(01919.HK)升4.9%。
金融股方面,汇控(00005.HK)升0.2%报48.55元,港交所(00388.HK)跌0.9%报453.6元,友邦(01299.HK)升0.1%报101.7元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.